Last Updated: November 13, 2026

Details for New Drug Application (NDA): 217815

« Back to Dashboard

NDA 217815 describes AMMONIUM LACTATE, which is a drug marketed by Padagis Israel, Sun Pharma Canada, Watson Labs Inc, and Zydus Lifesciences, and is included in eight NDAs. It is available from seven suppliers. Additional details are available on the AMMONIUM LACTATE profile page.

The generic ingredient in AMMONIUM LACTATE is ammonium lactate. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the ammonium lactate profile page.

Summary for 217815

Tradename:	AMMONIUM LACTATE
Applicant:	Zydus Lifesciences
Ingredient:	ammonium lactate
Patents:	0

Pharmacology for NDA: 217815

Mechanism of Action	Acidifying Activity

Suppliers and Packaging for NDA: 217815

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
AMMONIUM LACTATE	ammonium lactate	CREAM;TOPICAL	217815	ANDA	Zydus Lifesciences Limited	70771-1988	70771-1988-6	2 TUBE in 1 CARTON (70771-1988-6) / 140 g in 1 TUBE (70771-1988-5)
AMMONIUM LACTATE	ammonium lactate	CREAM;TOPICAL	217815	ANDA	Zydus Lifesciences Limited	70771-1988	70771-1988-7	385 g in 1 BOTTLE (70771-1988-7)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	EQ 12% BASE
Approval Date:	Feb 12, 2026	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.